Experience

Davis Polk advised ADC Therapeutics SA in connection with its entry into a facility agreement with Deerfield Partners, L.P., pursuant to which Deerfield agreed to extend senior secured…

Davis Polk advised the representatives of the underwriters, in connection with the SEC-registered offering by Biogen Inc. of $1.5 billion principal amount of 2.250% senior notes due 2030…

Davis Polk advised the representatives of the several underwriters, in connection with an SEC-registered offering by Snap-on Incorporated of $500 million aggregate principal amount of its 3…

Davis Polk is advising SS&C Technologies Holdings, Inc. on its $120 million acquisition of Innovest Systems, LLC. The transaction is expected to close in the second quarter of 2020. SS…

Davis Polk advised the forward purchasers and forward sellers in connection with an at-the-market forward underwriting program for the offer and sale of shares of common stock of CMS Energy…

Davis Polk advised the joint book-running managers on an SEC-registered offering by Diageo Capital plc of $750 million aggregate principal amount of 1.375% fixed-rate notes due 2025, …

Davis Polk advised the representatives of the underwriters in connection with an SEC-registered offering by Emerson Electric Co. of $500 million aggregate principal amount of 1.800%…

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with an SEC-registered offering by IDEX Corporation of $500 million…

Davis Polk advised the representatives of the several underwriters, in connection with the initial public offering of 36,000,000 units of CC Neuberger Principal Holdings I, including 5,400…

Davis Polk advised Morgan Stanley in connection with its SEC-registered global offering of $3 billion aggregate principal amount of fixed-to-floating-rate senior notes due 2026. During the…